联合应用噻托溴铵与沙美特罗/氟替卡松治疗中重度COPD稳定期的临床观察(2)
第1页 |
参见附件。
综上所述,联合使用噻托溴铵和沙美特罗/丙酸氟替卡松可以更好地改善COPD患者的肺功能和血气情况,不良反应少,对于COPD患者提高生活质量有着重要的临床意义。
[参考文献]
[1] 梁宪梅. 噻托溴铵治疗慢性阻塞性肺疾病疗效观察[J]. 中国医药导报,2011,8(8):67-68.
[2] 姚婉贞,常春. 支气管舒张剂和吸入糖皮质激素在慢性阻塞性肺疾病中的应用[J]. 中华结核和呼吸杂志,2007,30(3):223.
[3] Sin DD,Man SF,Marciniuk DD,et al. The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease[J]. Am J Respir Cir Care Med,2008,177(11):1207-1214.
[4] 文继辉. 舒利迭吸入治疗慢性阻塞性肺病的临床对照观察[J]. 中国医药导报,2010,7(7):57-58.
[5] Calverley PM,Anderson JA,Celli B,et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease[J]. N Engl J Med,2007,356(8):775-789.
[6] Celli BR,MacNee W,ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD:a summary of the ATS/ERS position paper[J]. Eur Respir J,2004,23(6):932-946.
[7] Brashier B. Tiotropium administered by a pressurized metered dose inhaler(pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD[J]. Respir Med,2007,101(12):2464-2471.
(收稿日期:2012-10-31 本文编辑:郭静娟)
您现在查看是摘要介绍页,详见PDF附件(2069kb)。